TAYLOR SWINEA: Open Payments
NPI 1740788413 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 91 payments from 16 companies in 2025. Trend: 2023 $1,812 · 2024 $1,753 · 2025 $1,993
Food & beverage: $1,894Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $400 |
| Janssen Biotech, Inc. | 12 | $367 |
| Amgen Inc. | 16 | $292 |
| UCB, Inc. | 12 | $275 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Mallinckrodt Hospital Products Inc. | 6 | $111 |
| GENZYME CORPORATION | 3 | $83 |
| ANI Pharmaceuticals, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $53 |
| Radius Health, Inc. | 2 | $50 |
Products named: TREMFYA, Bimzelx, RINVOQ, SKYRIZI, COSENTYX, ACTHAR, OTEZLA, KEVZARA.
Industry payments across GA — which companies pay providers there.
